Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 5MB, 226 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 7 results:
Author Title [ Type(Desc)] Year
Filters: Author is MacLachlan, S.  [Clear All Filters]
Journal Article
K. van Brunt, Curtis, B., Ivanyi, T., Balogh, E., Chalkiadaki, C., MacLachlan, S., Neasham, D., and Raluy-Callado, M., Basal-bolus Therapy in Patients with Type 2 Diabetes Mellitus in the UK: Patient Characteristics, Treatment Patterns and the Effect of Switching to Premixed Insulin, Diabetes Ther, vol. 7, pp. 793-807, 2016.
E. Merinopoulou, Raluy-Callado, M., Ramagopalan, S., MacLachlan, S., and Khalid, J. M., COPD exacerbations by disease severity in England, Int J Chron Obstruct Pulmon Dis, vol. 11, pp. 697-709, 2016.
L. Horne, Ashfaq, A., MacLachlan, S., Sinsakul, M., Qin, L., LoCasale, R., and Wetmore, J. B., Epidemiology and health outcomes associated with hyperkalemia in a primary care setting in England, BMC Nephrol, vol. 20, p. 85, 2019.
L. Harris, Graham, S., MacLachlan, S., Exuzides, A., and Jacob, S., Healthcare resource utilization by patients with treatment-refractory myasthenia gravis in England, J Med Econ, pp. 1-7, 2019.
D. Z. I. Cherney, Repetto, E., Wheeler, D. C., Arnold, S. V., MacLachlan, S., Hunt, P. R., Chen, H., Vora, J., and Kosiborod, M., Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus, Am J Nephrol, pp. 1-9, 2019.
C. Zecca, Disanto, G., Sacco, R., MacLachlan, S., Kuhle, J., Ramagopalan, S. V., and Gobbi, C., Increasing cancer risk over calendar year in people with multiple sclerosis: a case-control study, J Neurol, 2020.
G. Disanto, Zecca, C., MacLachlan, S., Sacco, R., Handunnetthi, L., Meier, U. C., Simpson, A., McDonald, L., Rossi, A., Benkert, P., Kuhle, J., Ramagopalan, S. V., and Gobbi, C., Prodromal symptoms of multiple sclerosis in primary care, Ann Neurol, vol. 83, pp. 1162-1173, 2018.
[Page last reviewed 6 April 2021]